Hospital
Herrick Memorial Hospital, INC.
Herrick Memorial Hospital, INC. was paid $1.82M by Medicaid between Jan 2018 and Sep 2020, across 76 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoHERRICK MEMORIAL HOSPITAL, INC.
TECUMSEH, MI 49286
TECUMSEH, MI 49286
33aNPI1982665642assigned 03/31/2006
33bProvider typeCritical Access Hospital
28Total paid$1.82M
24GClaims43,182
24DCodes billed76
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#24 of 31
Median peer was paid$6.03M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,256 | $670K | |
| 2019 | 16,750 | $680K | |
| 2020 | 9,176 | $474K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 4,791 | 4,233 | $566K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 2,067 | 1,909 | $364K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 877 | 839 | $213K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.6% | 1,500 | 1,328 | $120K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.3% | 1,416 | 1,332 | $115K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.8% | 399 | 391 | $51K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.6% | 918 | 916 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.2% | 549 | 511 | $40K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 1,374 | 1,147 | $36K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 429 | 421 | $36K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 1,381 | 1,152 | $30K |
| 71046 | Radiologic examination, chest; 2 views | 1.5% | 1,002 | 966 | $28K |
64 more codes
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.3% | 30 | $24K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 528 | $21K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.0% | 581 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 230 | $15K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 594 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 403 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 839 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 85 | $8K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 16 | $5K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $5K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 13 | $5K |
| 95811 | <1% | 12 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 503 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 2,697 | $3K |
| 76830 | Ultrasound, transvaginal | <1% | 53 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,204 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,242 | $2K |
| 76642 | <1% | 79 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 312 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 169 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,822 | $2K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 32 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 28 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,237 | $1K |
| 80061 | Lipid panel | <1% | 153 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 533 | $926.03 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 35 | $808.60 |
| 84439 | <1% | 252 | $788.11 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 185 | $765.39 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $753.85 |
| 83735 | <1% | 1,002 | $399.00 | |
| 72100 | <1% | 27 | $391.07 | |
| 85610 | <1% | 868 | $353.14 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 468 | $345.44 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $250.17 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 143 | $202.87 |
| 73630 | <1% | 56 | $185.10 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 320 | $109.42 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 339 | $103.76 |
| 85379 | <1% | 263 | $78.04 | |
| 83690 | <1% | 905 | $74.32 | |
| 82150 | <1% | 477 | $57.13 | |
| 73562 | <1% | 17 | $52.35 | |
| 81003 | <1% | 1,584 | $49.57 | |
| 85730 | <1% | 666 | $44.25 | |
| 81025 | <1% | 969 | $43.21 | |
| 85027 | <1% | 12 | $39.92 | |
| 81001 | <1% | 209 | $37.80 | |
| 73610 | <1% | 26 | $31.59 | |
| 83880 | <1% | 14 | $21.33 | |
| 84484 | <1% | 868 | $15.84 | |
| 96376 | 0% | 202 | $0.00 | |
| 87040 | 0% | 41 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 402 | $0.00 |
| 84703 | 0% | 53 | $0.00 | |
| 87807 | 0% | 27 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 61 | $0.00 |
| 94760 | 0% | 74 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 0% | 32 | $0.00 |
| 83605 | 0% | 19 | $0.00 | |
| 94664 | 0% | 339 | $0.00 | |
| L8613 | Ossicula implant | 0% | 12 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHARP, KEVIN (VP REV CYCLE)
Parent organizationPROMEDICA HEALTH SYSTEM, INC.
| Provider | Location | Paid |
|---|---|---|
| The Toledo Hospital | Toledo, OH | $151.22M |
| Emma L. Bixby Medical Center | Adrian, MI | $18.35M |
| Bay Park Community Hospital | Oregon, OH | $16.39M |
| Community Health Center of Branch County | Coldwater, MI | $11.80M |
| Defiance Hospital INC. | Defiance, OH | $11.55M |
| Memorial Hospital | Fremont, OH | $11.40M |
| Fostoria Hospital Association | Fostoria, OH | $7.48M |
| Toledo Hospital | Toledo, OH | $2.38M |
| Flower Hospital | Sylvania, OH | $368K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.